• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Long-term mortality of coronary artery bypass grafting and bare-metal stenting.冠状动脉旁路移植术和金属裸支架的长期死亡率。
Ann Thorac Surg. 2011 Dec;92(6):2132-8. doi: 10.1016/j.athoracsur.2011.06.061. Epub 2011 Oct 19.
2
The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study:5 年随访:多血管病变糖尿病患者经皮冠状动脉介入治疗与冠状动脉旁路移植术血运重建的比较。
J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):26-33. doi: 10.2459/JCM.0b013e328330ea32.
3
Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents.药物洗脱支架冠状动脉旁路移植术和支架置入术的长期死亡率。
Ann Thorac Surg. 2013 Apr;95(4):1297-305. doi: 10.1016/j.athoracsur.2012.11.073. Epub 2013 Feb 4.
4
Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II).西罗莫司洗脱支架、裸金属支架或冠状动脉旁路移植术用于多支血管病变患者,包括左前降支近端受累:动脉血运重建治疗研究第2部分(ARTS-II)分析
Heart. 2009 Jul;95(13):1061-6. doi: 10.1136/hrt.2008.157735. Epub 2009 Mar 19.
5
Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.无保护左主干冠状动脉疾病支架置入与冠状动脉旁路移植术的长期结局:ASAN-MAIN(ASAN 医疗中心-左主干血运重建)注册研究中裸金属支架 10 年和药物洗脱支架 5 年的结果。
J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097.
6
Long-term outcomes of coronary-artery bypass grafting versus stent implantation.冠状动脉旁路移植术与支架植入术的长期疗效
N Engl J Med. 2005 May 26;352(21):2174-83. doi: 10.1056/NEJMoa040316.
7
Very Long-Term (10 to 14 Year) Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Multivessel Coronary Artery Disease in the Bare-Metal Stent Era.在裸金属支架时代经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗多支冠状动脉疾病的 10 至 14 年的长期结果。
Circ Cardiovasc Interv. 2016 Aug;9(8). doi: 10.1161/CIRCINTERVENTIONS.115.003365.
8
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较:外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
9
Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.多动脉旁路移植可改善多支血管病变患者冠状动脉血运重建术后早期主要心脏和脑血管不良事件的发生率:12615 例患者分析。
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):746-752. doi: 10.1093/ejcts/ezx171.
10
Significance of off-pump coronary artery bypass grafting compared with percutaneous coronary intervention: a propensity score analysis.非体外循环冠状动脉旁路移植术与经皮冠状动脉介入治疗的意义:倾向评分分析。
Eur J Cardiothorac Surg. 2012 Jan;41(1):94-101. doi: 10.1016/j.ejcts.2011.04.004.

引用本文的文献

1
Outcomes of trauma admission for falls: influence of race and age on inhospital and post-discharge mortality.跌倒所致创伤入院的结局:种族和年龄对住院期间及出院后死亡率的影响。
Am J Surg. 2016 Oct;212(4):638-644. doi: 10.1016/j.amjsurg.2016.06.002. Epub 2016 Jul 18.
2
Trauma Recidivism Predicts Long-term Mortality: Missed Opportunities for Prevention (Retrospective Cohort Study).创伤再发预示长期死亡率:预防的错失机遇(回顾性队列研究)
Ann Surg. 2017 May;265(5):847-853. doi: 10.1097/SLA.0000000000001823.
3
CABG in 2012: Evidence, practice and the evolution of guidelines.2012年的冠状动脉旁路移植术:证据、实践与指南的演变
Glob Cardiol Sci Pract. 2013 Nov 1;2012(2):21-8. doi: 10.5339/gcsp.2012.20. eCollection 2012.
4
Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI.306868例多支冠状动脉疾病患者的长期死亡率:冠状动脉旁路移植术与经皮冠状动脉介入治疗的比较
Br J Med Med Res. 2013 Oct;3(4):1248-1257. doi: 10.9734/bjmmr/2013/3380.
5
Association between intentional injury and long-term survival after trauma.创伤后蓄意伤害与长期生存的关系。
Ann Surg. 2014 May;259(5):985-92. doi: 10.1097/SLA.0000000000000486.
6
Stents or surgery in coronary artery disease in 2013.2013 年冠状动脉疾病的支架或手术。
Ann Cardiothorac Surg. 2013 Jul;2(4):431-4. doi: 10.3978/j.issn.2225-319X.2013.07.20.
7
Coronary artery revascularization evaluation--a multicenter registry with seven years of follow-up.冠状动脉血运重建评估——一项包含七年随访的多中心注册研究。
J Am Heart Assoc. 2013 Apr 18;2(2):e000162. doi: 10.1161/JAHA.113.000162.
8
Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents.药物洗脱支架冠状动脉旁路移植术和支架置入术的长期死亡率。
Ann Thorac Surg. 2013 Apr;95(4):1297-305. doi: 10.1016/j.athoracsur.2012.11.073. Epub 2013 Feb 4.

本文引用的文献

1
Acceptance, panic, and partial recovery the pattern of usage of drug-eluting stents after introduction in the U.S. (a report from the American College of Cardiology/National Cardiovascular Data Registry).药物洗脱支架在美国引入后的使用模式:接受、恐慌和部分恢复(美国心脏病学会/国家心血管数据注册中心报告)。
JACC Cardiovasc Interv. 2010 Sep;3(9):902-10. doi: 10.1016/j.jcin.2010.06.014.
2
Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.十年随访的医学、血管成形术或手术研究(MASS II):多血管冠状动脉疾病 3 种治疗策略的随机对照临床试验。
Circulation. 2010 Sep 7;122(10):949-57. doi: 10.1161/CIRCULATIONAHA.109.911669. Epub 2010 Aug 23.
3
Drug-eluting stents: a study of international practice.药物洗脱支架:一项国际实践研究。
Am Heart J. 2009 Oct;158(4):576-84. doi: 10.1016/j.ahj.2009.07.033.
4
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.多支血管病变的冠状动脉搭桥手术与经皮冠状动脉介入治疗的比较:来自十项随机试验的个体患者数据的协作分析
Lancet. 2009 Apr 4;373(9670):1190-7. doi: 10.1016/S0140-6736(09)60552-3. Epub 2009 Mar 19.
5
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗严重冠状动脉疾病的比较
N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18.
6
Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.经皮冠状动脉介入治疗联合支架置入术与冠状动脉旁路移植术治疗多支冠状动脉疾病的长期安全性和疗效:一项基于ARTS、ERACI-II、MASS-II和SoS试验5年患者水平数据的荟萃分析。
Circulation. 2008 Sep 9;118(11):1146-54. doi: 10.1161/CIRCULATIONAHA.107.752147. Epub 2008 Aug 25.
7
Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS).多支冠状动脉疾病患者冠状动脉搭桥手术与经皮冠状动脉介入治疗的随机对照试验:支架或手术试验(SoS)的六年随访
Circulation. 2008 Jul 22;118(4):381-8. doi: 10.1161/CIRCULATIONAHA.107.739144. Epub 2008 Jul 7.
8
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.药物洗脱支架与冠状动脉旁路移植术治疗多支冠状动脉疾病的比较
N Engl J Med. 2008 Jan 24;358(4):331-41. doi: 10.1056/NEJMoa071804.
9
Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement.2004年至2006年心血管外科文献中的倾向评分匹配:系统评价与改进建议
J Thorac Cardiovasc Surg. 2007 Nov;134(5):1128-35. doi: 10.1016/j.jtcvs.2007.07.021.
10
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.系统评价:经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较疗效
Ann Intern Med. 2007 Nov 20;147(10):703-16. doi: 10.7326/0003-4819-147-10-200711200-00185. Epub 2007 Oct 15.

冠状动脉旁路移植术和金属裸支架的长期死亡率。

Long-term mortality of coronary artery bypass grafting and bare-metal stenting.

机构信息

Department of Public Health Sciences, Penn State Hershey College of Medicine, Hershey, Pennsylvania 17033, USA.

出版信息

Ann Thorac Surg. 2011 Dec;92(6):2132-8. doi: 10.1016/j.athoracsur.2011.06.061. Epub 2011 Oct 19.

DOI:10.1016/j.athoracsur.2011.06.061
PMID:22014747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3271851/
Abstract

BACKGROUND

There is little information on relative survival with follow-up longer than 5 years in patients undergoing coronary artery bypass grafting (CABG) and patients undergoing percutaneous coronary intervention (PCI) with stenting. This study tested the hypothesis that CABG is associated with a lower risk of long-term (8-year) mortality than is stenting with bare-metal stents for multivessel coronary disease.

METHODS

We identified 18,359 patients with multivessel disease who underwent isolated CABG and 13,377 patients who received bare-metal stenting in 1999 to 2000 in New York and followed their vital status through 2007 using the National Death Index (NDI). We matched CABG and stent patients on the number of diseased coronary vessels, proximal left anterior descending (LAD) artery disease, and propensity of undergoing CABG based on numerous patient characteristics and compared survival after the 2 procedures.

RESULTS

In the 7,235 pairs of matched patients, the overall 8-year survival rates were 78.0% for CABG and 71.2% for stenting (hazard ratio [HR], 0.68; 95% confidence interval [CI], 0.64 to 0.74; p < 0.001). For anatomic groups classified by the number of diseased vessels and proximal LAD involvement, the HRs ranged from 0.53 (p < 0.001) for patients with 3-vessel disease involving proximal LAD artery disease to 0.78 (p = 0.05) for patients with 2-vessel disease but no disease in the LAD artery. A lower risk of death after CABG was observed in all subgroups stratified by a number of baseline risk factors.

CONCLUSIONS

Coronary artery bypass grafting is associated with a lower risk of death than is stenting with bare metal stents for multivessel coronary disease.

摘要

背景

在接受冠状动脉旁路移植术(CABG)和经皮冠状动脉介入治疗(PCI)加支架治疗的患者中,随访时间超过 5 年的相对生存率信息较少。本研究检验了这样一个假设,即与裸金属支架置入术治疗多支血管病变相比,CABG 与长期(8 年)死亡率降低相关。

方法

我们在 1999 年至 2000 年期间确定了 18359 例接受单纯 CABG 治疗和 13377 例接受裸金属支架置入术治疗的多支血管病变患者,并通过国家死亡指数(NDI)跟踪其生命状态至 2007 年。我们根据许多患者特征,按病变冠状动脉数量、左前降支(LAD)近端疾病和 CABG 倾向性,对 CABG 与支架患者进行了匹配,并比较了两种治疗方法后的生存情况。

结果

在 7235 对匹配患者中,CABG 的总体 8 年生存率为 78.0%,支架置入术为 71.2%(风险比[HR],0.68;95%置信区间[CI],0.64 至 0.74;p < 0.001)。对于根据病变血管数量和 LAD 近端受累情况进行分类的解剖学亚组,HR 范围从涉及 LAD 近端病变的 3 支血管病变患者的 0.53(p < 0.001)到 2 支血管病变但 LAD 无病变患者的 0.78(p = 0.05)。在按多种基线风险因素分层的所有亚组中,CABG 后死亡风险均较低。

结论

与裸金属支架置入术治疗多支血管病变相比,冠状动脉旁路移植术与较低的死亡风险相关。